MedTrace Logo

Prediction of Childhood Epilepsy Outcome in Bangladesh

NCT00381537 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 92

Last updated 2006-12-25

No results posted yet for this study

Summary

Randomised controlled trial of the use of phenobarbitone and carbamazepine in childhood epilepsy in Bangladesh with particular reference to behavioural side effects.

Conditions

Interventions

DRUG

phenobarbitone

DRUG

carbamazepine

Sponsors & Collaborators

  • Institute of Child Health

    lead OTHER

Principal Investigators

  • Brian Neville, Professor · Institute of Child Health

  • Selina Banu, Dr · Children's Hospital Dhaka (Shishu) Bangladesh.

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
2 Years
Max Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Countries

  • Bangladesh
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00381537 on ClinicalTrials.gov